NAB1

Interactions

NAB1 has been shown to interact with Zif268.[5]

gollark: Why is staff a meme? Should I not be trying to revise my application‽
gollark: I am SERIOUSLY CONSIDERING partly rewriting my application to use Redux to hopefully make state management in it less problematic.
gollark: You should use RPNCalc's x86 target.
gollark: Æ writing this application to be better is hard.
gollark: > if one is going to be an overlord it's important to be regarded as an evil overlord because then when you want to enact policy that has immediate costs and long-term benefits, instead of having to tediously, endlessly justify why it's good you can just be like "[REDACTED] you i'm evil"Does this explain LyricLy?

References

  1. GRCh38: Ensembl release 89: ENSG00000138386 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000002881 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Russo MW, Sevetson BR, Milbrandt J (Aug 1995). "Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription". Proc Natl Acad Sci U S A. 92 (15): 6873–7. Bibcode:1995PNAS...92.6873R. doi:10.1073/pnas.92.15.6873. PMC 41432. PMID 7624335.
  6. Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, Milbrandt J (Aug 1996). "NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli". Mol Cell Biol. 16 (7): 3545–53. doi:10.1128/MCB.16.7.3545. PMC 231349. PMID 8668170.
  7. Swirnoff AH, Apel ED, Svaren J, Sevetson BR, Zimonjic DB, Popescu NC, Milbrandt J (Jan 1998). "Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain". Mol Cell Biol. 18 (1): 512–24. doi:10.1128/MCB.18.1.512. PMC 115883. PMID 9418898.
  8. "Entrez Gene: NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1)".

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.